复方甘草酸苷联合薄芝糖肽治疗结节性红斑疗效观察
Clinical investigation of compound glycyrrhizin combined with bozhi glycopeptide in treatment of erythema nodosum
殷河慧 1李国阳1
作者信息
- 1. 118000 辽宁丹东,解放军第二三○医院皮肤科
- 折叠
摘要
目的 观察复方甘草酸苷联合薄芝糖肽治疗结节性红斑的临床疗效.方法 选择64例结节性红斑患者,按随机数字表法分为治疗组(36例)和对照组(28例).治疗组给予注射用复方甘草酸苷120 mg,静脉滴注,1次/d;同时给予薄芝糖肽注射液4ml,静脉滴注,1次/d.对照组仅给予注射用复方甘草酸苷120 mg,静脉滴注,1次/d.观察两组临床疗效及复发情况.结果 治疗组总有效率显著高于对照组[86.1％(31/36)比57.1％(16/28)],差异有统计学意义(P＜0.05).随访3个月,治疗组复发率明显低于对照组[16.1％(5/31)比8/16],差异有统计学意义(P＜0.05).结论 复方甘草酸苷联合薄芝糖肽治疗结节性红斑有较好的临床疗效,并可显著降低复发率,值得临床推广应用.
Abstract
Objective To investigate the clinical effect and safety of compound glycyrrhizin combined with bozhi glycopeptide in treatment of erythema nodosum.Methods Sixty-four patients with erythema nodosum were divided into treatment group (36 cases) and control group (28 cases) by random digits table method.The patients in treatment group were given compound glycyrrhizin 120 mg,intravenous drip,once a day;and bozhi glycopeptide 4 ml,intravenous drip,once a day.The patients in control group were given compound glycyrrhizin 120 mg,intravenous drip,once a day.The clinical efficacy and recurrence were compared between 2 groups.Results The total effective rate in treatment group was significantly higher than that in control group [86.1％ (31/36) vs.57.1％ (16/28)],there was statistical difference (P ＜ 0.05).Follow-up for 3 months,the rate of recurrence in treatment group was significantly lower than that in control group [16.1％(5/31) vs.8/16],there was statistical difference (P＜ 0.05).Conclusion Compound glycyrrhizin combined with bozhi glycopeptide can effectively control the erythema nodosum,and has no significant adverse reactions,reduces the rate of recurrence,and it is worthy of promotion and application.
关键词
红斑,结节性/复方甘草酸苷/薄芝糖肽Key words
Erythema nodosum/Compound glycyrrhizin/Bozhi glycopeptide引用本文复制引用
出版年
2014
NETL
NSTL
维普
万方数据